Join Robert A. Harrington, M.D., the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, for a fireside chat with John Babich, Ph.D., president and chief scientific officer at Ratio Therapeutics, Inc. and former faculty of Weill Cornell Medicine. Dr. Babich has over 30 years of experience in radiopharmaceutical sciences and nuclear medicine, spanning academic, clinical and biotech/pharma settings.
Ratio Therapeutics, Inc., a clinical-stage company founded upon Weill Cornell Medicine technology invented by Dr. Babich and colleagues, is developing next-generation radiopharmaceuticals for cancer treatment. It closed a $70 million Series C financing in July 2026, bringing its total capital raised to $240 million.
Dean Harrington and Dr. Babich will explore important topics including technology development in academia, balancing the demands of an academic career and launching an innovation, fundraising in the current environment and spinning out companies.
The symposium also features an industry panel and a presentation by Teresa Sanchez, Ph.D., associate professor of pathology and laboratory medicine, on her Critical Path Institute BRIDGe award winning research on sepsis-associated neurocognitive dysfunction.
Participants will have an opportunity to network with like-minded researchers and innovators as well as industry representatives at the end.